Compare Alcon AG (ALC) vs AT&T Inc. (T) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Alcon AG vs AT&T Inc. — how do they compare? Alcon AG trades at $66.64 (market cap $32.69B), while AT&T Inc. trades at $21.12 (market cap $146.54B). The key difference: AT&T Inc. is far larger — about 4.5× Alcon AG's market cap, and AT&T Inc. pays the higher dividend (5.26%). Which is the better fit depends on your goals.
| ALC | T | |
|---|---|---|
Market Cap | $32.69B | $146.54B |
Sector | Health | Media |
52-Week High | $92.22 | $29.62 |
52-Week Low | $62.02 | $20.49 |
Enterprise Value | $36.28B | $291.89B |
Dividend Yield | 0.54% | 5.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ALC trades at $66.87, down 4.01% on the day, amid a mixed technical and fundamental backdrop. The stock exhibits a bullish technical signal overall, with moving averages supporting a positive trend, while oscillators remain neutral. Fundamentally, revenue growth is steady, reaching $10.40 billion in 2025, though net income margin compressed to 7.7%. Recent news highlights product innovation, including a collaboration with RxSight for adjustable PCIOLs, signaling ongoing R&D investment. Analyst sentiment is predominantly positive, with a consensus price target of $86.00 implying significant upside.
The outlook for ALC is cautiously optimistic, driven by new product launches and strategic partnerships that may fuel growth. However, risks include competitive pressures, macroeconomic headwinds, and margin compression. With a P/E of 40.92, the valuation appears rich relative to historical norms, requiring strong earnings delivery to justify current levels. Investors should weigh robust analyst buy ratings against execution risks and market volatility.
AT&T (T) trades at $21.06, up 2.38% today but remains near multi-year lows amid competitive pressures. The stock shows bearish technical signals with key support at $20, while fundamentals reveal strong profitability with a 16.94% net margin and attractive valuation at a P/E of 6.93. Recent earnings beats and a 5.4% dividend yield provide support, but SpaceX competition concerns dominate sentiment.
Outlook: Undervalued with significant upside to the $29.50 consensus target, but high debt and Starlink disruption risks temper near-term optimism. Investment case hinges on execution in fiber/wireless growth against stiff competition, with cash flow stability supporting the dividend.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Alcon AG
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
